Fund Tracker India by Ishaan Dungarwal
Guide

Tata India Pharma & Healthcare Fund

Holdings for Oct 2026, changes against Sep 2026, from Tata Mutual Fund's monthly file.

Tata India Pharma & Healthcare Fund portfolio holdings, Oct 2026: 40 stocks, ₹1,495 cr in listed equity, from Tata Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Rajat Srivastava

Benchmark: BSE Healthcare TRI · Riskometer: Very High · SEBI category, as filed: Sectoral Fund · Allotted 28 Dec 2015

Source: AMFI scheme summary document

NAV

Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

Source: AMFI

₹40.229620 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹1,534 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.23 %, regular 2.40 % (174 schemes) · Regular costs ₹1,310 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 0.62 %, regular 1.79 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 21 Nov 2026. Source: AMFI · Glossary: TER

Direct 1.09 %Regular 2.40 %
Equity held

40 stocks, Oct 2026.

Source: Tata Mutual Fund monthly portfolio

₹1,495 cr40 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 50.1%.

99.7%top 10 stocks 50.1%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 12 months to Oct 2026
Nov 2025: equity held ₹1,272 cr, 34 stocks, NAV ₹36.14Dec 2025: equity held ₹1,293 cr, 36 stocks, NAV ₹35.37Jan 2026: equity held ₹1,228 cr, 34 stocks, NAV ₹33.46Feb 2026: equity held ₹1,270 cr, 34 stocks, NAV ₹35.24Mar 2026: equity held ₹1,226 cr, 38 stocks, NAV ₹33.02Apr 2026: equity held ₹1,320 cr, 37 stocks, NAV ₹35.32May 2026: equity held ₹1,377 cr, 38 stocks, NAV ₹36.78Jun 2026: equity held ₹1,418 cr, 34 stocks, NAV ₹38.12Jul 2026: equity held ₹1,528 cr, 37 stocks, NAV ₹39.79Aug 2026: equity held ₹1,558 cr, 41 stocks, NAV ₹40.05Sep 2026: equity held ₹1,507 cr, 42 stocks, NAV ₹38.30Oct 2026: equity held ₹1,495 cr, 40 stocks, NAV ₹37.77
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsJul 2026▼ −2.2%▼ −5.1%
6 monthsApr 2026▲ +13.3%▲ +6.9%
12 monthsOct 2025▲ +14.6%▲ +5.2%
MonthEquity heldStocksNAV at month end
Nov 2025₹1,272 cr34₹36.1355
Dec 2025₹1,293 cr36₹35.3723
Jan 2026₹1,228 cr34₹33.4597
Feb 2026₹1,270 cr34₹35.2393
Mar 2026₹1,226 cr38₹33.0201
Apr 2026₹1,320 cr37₹35.3246
May 2026₹1,377 cr38₹36.7782
Jun 2026₹1,418 cr34₹38.1238
Jul 2026₹1,528 cr37₹39.7889
Aug 2026₹1,558 cr41₹40.0470
Sep 2026₹1,507 cr42₹38.3028
Oct 2026₹1,495 cr40₹37.7655
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New1
  • Added12
  • Trimmed7
  • Exited3
Stocks, by share count · Source: Tata Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    99.7%
  2. Rest, not itemised
    0.3%
Source: Tata Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
Source: Tata Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Small Cap
    40.2%
  2. Mid Cap
    30.5%
  3. Large Cap
    26.8%
  4. Not in AMFI's list
    2.4%
Source: Tata Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 50.1% together
Source: Tata Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Sector weight change

Each sector's share of the fund now less a month before. It moves with prices as well as trades.

vs Sep 2026 · points of equity held
Source: Tata Mutual Fund monthly portfolios

Largest moves first, up to 10.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

23 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
NESTLEIND New—1.40 lakh+1.40 lakh—+₹16.3 cr₹16.3 cr
TORNTPHARM Added1.19 lakh1.54 lakh+35,282+29.8%+₹16.3 cr₹70.9 cr
MAXHEALTH Added6.03 lakh7.45 lakh+1.42 lakh+23.5%+₹12.2 cr₹64.1 cr
SAILIFE Added2.58 lakh3.09 lakh+51,372+19.9%+₹8.0 cr₹48.2 cr
PGHL Added74,59683,211+8,615+11.5%+₹4.9 cr₹47.2 cr
ANTHEM Added4.53 lakh5.40 lakh+87,486+19.3%+₹7.3 cr₹44.8 cr
NATCOPHARM Added2.75 lakh5.47 lakh+2.72 lakh+98.8%+₹21.3 cr₹42.8 cr
FDC Added9.97 lakh10.70 lakh+72,675+7.3%+₹2.7 cr₹40.3 cr
ASTERDM Added3.62 lakh5.13 lakh+1.51 lakh+41.5%+₹10.3 cr₹34.9 cr
BIOCON Added2.80 lakh9.52 lakh+6.72 lakh+240.3%+₹23.6 cr₹33.5 cr
NAVINFLUOR Added21,57237,188+15,616+72.4%+₹13.6 cr₹32.3 cr
SANOFICONR Added22,80986,611+63,802+279.7%+₹22.0 cr₹29.8 cr
AGARWALEYE Added2.15 lakh3.85 lakh+1.70 lakh+79.0%+₹8.7 cr₹19.6 cr
DIVISLAB Trimmed92,36182,875−9,486−10.3%−₹9.3 cr₹81.1 cr
CIPLA Trimmed4.74 lakh3.35 lakh−1.39 lakh−29.3%−₹19.1 cr₹46.2 cr
ALKEM Trimmed69,05840,998−28,060−40.6%−₹14.3 cr₹21.0 cr
SYMBIOTEC Trimmed1.12 lakh58,291−53,968−48.1%−₹6.7 cr₹7.3 cr
PIIND Trimmed1.70 lakh33,170−1.36 lakh−80.4%−₹28.6 cr₹7.0 cr
LALPATHLAB Trimmed1.34 lakh2,113−1.32 lakh−98.4%−₹25.2 cr₹0.40 cr
IPCALAB Trimmed71,53688−71,448−99.9%−₹13.8 cr₹0.02 cr
FORTIS Exited3.83 lakh—−3.83 lakh—−₹29.5 cr₹29.5 cr
MANKIND Exited46,256—−46,256—−₹11.6 cr₹11.6 cr
JUBLPHARMA Exited49—−49—−₹0.01 cr₹0.01 cr
Source: Tata Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (40 stocks)

Every listed stock in the month's file, largest first.

largest first, by value
Company Sector
SUNPHARMASun Pharmaceutical Industries Limited Healthcare6.65 lakh₹118 cr7.89%
ABBOTINDIAAbbott India Limited Healthcare33,086₹84.8 cr5.66%
DIVISLABDivi's Laboratories Limited Healthcare82,875₹81.1 cr5.41%
HCGHealthcare Global Enterprises Limited Healthcare13.44 lakh₹78.7 cr5.25%
DRREDDYDr. Reddy's Laboratories Limited Healthcare5.70 lakh₹77.1 cr5.14%
TORNTPHARMTorrent Pharmaceuticals Limited Healthcare1.54 lakh₹70.9 cr4.73%
APOLLOHOSPApollo Hospitals Enterprise Limited Healthcare80,707₹68.2 cr4.55%
MAXHEALTHMax Healthcare Institute Limited Healthcare7.45 lakh₹64.1 cr4.28%
RAINBOWRainbow Childrens Medicare Limited Healthcare4.95 lakh₹60.3 cr4.02%
SAILIFESai Life Sciences Limited Healthcare3.09 lakh₹48.2 cr3.22%
SYNGENESyngene International Limited Healthcare11.80 lakh₹47.5 cr3.17%
PGHLProcter & Gamble Health Limited Healthcare83,211₹47.2 cr3.15%
LUPINLupin Limited Healthcare2.33 lakh₹46.9 cr3.13%
CIPLACipla Limited Healthcare3.35 lakh₹46.2 cr3.08%
ANTHEMAnthem Biosciences Limited Healthcare5.40 lakh₹44.8 cr2.99%
NATCOPHARMNatco Pharma Limited Healthcare5.47 lakh₹42.8 cr2.86%
FDCFDC Limited Healthcare10.70 lakh₹40.3 cr2.69%
BAYERCROPBayer Cropscience Limited Chemicals1.23 lakh₹40.1 cr2.68%
PFIZERPfizer Limited Healthcare97,680₹36.0 cr2.40%
ACUTAASAcutaas Chemicals Limited Healthcare89,770₹35.9 cr2.40%
ASTERDMAster DM Quality Care Limited Healthcare5.13 lakh₹34.9 cr2.33%
BIOCONBiocon Limited Healthcare9.52 lakh₹33.5 cr2.23%
NAVINFLUORNavin Fluorine International Limited Chemicals37,188₹32.3 cr2.15%
SANOFICONRSanofi Consumer Healthcare India Limited Healthcare86,611₹29.8 cr1.99%
AJANTPHARMAjanta Pharma Limited Healthcare68,052₹23.9 cr1.59%
ALKEMAlkem Laboratories Limited Healthcare40,998₹21.0 cr1.40%
AGARWALEYEDr Agarwals Health Care Limited Healthcare3.85 lakh₹19.6 cr1.31%
GILLETTEGillette India Limited Fast Moving Consumer Goods26,534₹18.8 cr1.25%
NESTLEINDNestle India Limited Fast Moving Consumer Goods1.40 lakh₹16.3 cr1.09%
SUMICHEMSumitomo Chemical India Limited Chemicals4.80 lakh₹15.1 cr1.01%
PRASOLCHEMPRASOL CHEMICALS LTD Chemicals1.58 lakh₹12.7 cr0.85%
GLAXOGlaxosmithkline Pharmaceuticals Ltd. Healthcare41,697₹10.4 cr0.69%
ZIMLABZim Laboratories Limited Healthcare6.31 lakh₹8.6 cr0.57%
MANIPALHOSManipal Health Enterprises Ltd Healthcare1.27 lakh₹8.5 cr0.57%
MOLBIOMolbio Diagnostics Limited Healthcare61,965₹7.9 cr0.53%
FLUOROCHEMGujarat Fluorochemicals Limited Chemicals18,164₹7.7 cr0.51%
SYMBIOTECSymbiotec Pharmalab Limited Healthcare58,291₹7.3 cr0.48%
PIINDPI Industries Limited Chemicals33,170₹7.0 cr0.46%
LALPATHLABDr. Lal Path Labs Limited Healthcare2,113₹0.40 cr0.03%
IPCALABIPCA Laboratories Limited Healthcare88₹0.02 cr0.00%
Show all 40 stocksShow the first 15

Equity rows as disclosed, Oct 2026. Source: Tata Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202626.8%30.4%40.2%2.4%Jun 2026
Sep 202626.0%33.9%37.0%2.9%Jun 2026
Aug 202623.3%36.1%37.3%2.8%Jun 2026
Jul 202623.4%32.0%42.8%1.0%Jun 2026
Jun 202634.0%24.6%38.8%0.0%Dec 2025
May 202635.2%23.6%40.6%0.0%Dec 2025
Apr 202635.5%24.1%40.0%0.0%Dec 2025
Mar 202635.8%24.2%39.6%0.0%Dec 2025
Feb 202636.0%20.8%40.7%0.0%Dec 2025
Jan 202633.6%24.3%41.2%0.0%Dec 2025
Dec 202536.9%21.8%38.8%1.2%Jun 2025
Nov 202536.5%19.6%38.8%0.0%Jun 2025
Sources: Tata Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 12 months97.2%Oct 2025 to Oct 2026 · bought ₹1,461 cr, sold ₹1,327 cr
MonthBoughtSoldTurnover
Oct 2026₹167 cr₹158 cr10.5%
Sep 2026₹174 cr₹152 cr9.9%
Aug 2026₹193 cr₹175 cr11.3%
Jul 2026₹148 cr₹91.2 cr6.2%
Jun 2026₹95.6 cr₹105 cr6.8%
May 2026₹94.2 cr₹91.6 cr6.8%
Apr 2026₹32.0 cr₹24.1 cr1.9%
Mar 2026₹108 cr₹68.8 cr5.5%
Feb 2026₹45.3 cr₹71.9 cr3.6%
Jan 2026₹90.9 cr₹84.3 cr6.7%
Dec 2025₹147 cr₹95.3 cr7.4%
Nov 2025₹167 cr₹211 cr12.9%
Source: Tata Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns, Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

What the plan's NAV did over each period, as AMFI publishes it.

NAV to NAV · Source: AMFI
PeriodReturnFromTo
1 year+11.82 % in total 20 Nov 2025 · NAV ₹35.977620 Nov 2026 · NAV ₹40.2296
3 years+18.74 % a year, compounded 20 Nov 2023 · NAV ₹24.018320 Nov 2026 · NAV ₹40.2296
5 years+16.00 % a year, compounded 18 Nov 2021 · NAV ₹19.132520 Nov 2026 · NAV ₹40.2296
Since first NAV+13.58 % a year, compounded 29 Dec 2015 · NAV ₹10.035120 Nov 2026 · NAV ₹40.2296

Past performance may not be sustained in future.

Source: AMFI NAV files

Change in the plan's NAV between the two dates shown, as AMFI publishes the NAVs (plan code 135810).

How to read

Report a wrong number

IDCW (dividend) history

0 declarations · as of 2 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Rolling returns, Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

weekly NAVs · Source: AMFI
WindowLowestMedianHighestWindows above zero
1 year in total −18.55 % 5 Aug 2016 to 11 Aug 2017+9.08 % 4 Jul 2025 to 10 Jul 2026+78.25 % 27 Mar 2020 to 1 Apr 2021 71 % of 510 windows ending 6 Jan 2017 to 20 Nov 2026
3 years a year, compounded −3.20 % 1 Jan 2016 to 4 Jan 2019+21.08 % 3 Sep 2021 to 6 Sep 2024+29.90 % 20 Jul 2018 to 23 Jul 2021 91 % of 412 windows ending 4 Jan 2019 to 20 Nov 2026
5 years a year, compounded +9.26 % 29 Jan 2016 to 29 Jan 2021+16.43 % 6 Oct 2017 to 7 Oct 2022+31.33 % 11 Oct 2019 to 11 Oct 2024 100 % of 308 windows ending 1 Jan 2021 to 20 Nov 2026

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

Every 1-, 3- and 5-year window ending on a week's last NAV, lowest, middle and highest.

Volatility, a year

Standard deviation of weekly NAV changes × √52. 24 Nov 2023 to 20 Nov 2026, 156 weekly changes.

Source: AMFI

14.47 %156 weeks to 20 Nov 2026
Largest fall from a high

High 29 Jan 2016, low 11 Aug 2017; back at the high 31 Aug 2018.

Weekly NAVs since 1 Jan 2016. Measured on each week's last NAV, so a fall within a week can be deeper than shown.

Source: AMFI

−19.12 %low 11 Aug 2017

Past performance may not be sustained in future.

Next to its category: Sectoral or thematic

weekly NAVs · Source: AMFI
Rolling windowLower quarterUpper quarterAbove 6 %Above 9 %Above 12 %Above the category average
1 year−1.0 %+31.2 % 57.3 %50.2 %44.1 % 48.0 % of 510 windows
3 years+16.6 %+24.1 % 84.2 %82.3 %80.1 % 64.3 % of 412 windows
5 years+14.9 %+23.2 % 100.0 %100.0 %95.5 % 62.0 % of 308 windows
How this is counted

Same windows as the rolling returns above. A quarter of the windows returned less than the lower quarter, and a quarter more than the upper. "Above" columns give the share of windows. The category average is the average for windows ending the same week.

Market phases

PhaseDatesThis schemeCategory average
Rise, 2016–1826 Feb 2016 to 31 Aug 2018 a year, compounded+2.5 %+23.8 % 55 schemes
To the COVID low31 Aug 2018 to 27 Mar 2020 a year, compounded−7.3 %−17.9 % 58 schemes
Rise from the COVID low27 Mar 2020 to 27 Sep 2024 a year, compounded+35.9 %+37.3 % 70 schemes
Foreign selling, 2024–2527 Sep 2024 to 28 Feb 2025 in total−14.8 %−19.1 % 148 schemes
Since March 202528 Feb 2025 to 20 Nov 2026 a year, compounded+16.9 %+15.6 % 165 schemes

The phases are the site's own split of the market since 2015, measured from month end to month end.

From each quarter end to the newest NAV

FromDatesThis schemeCategory average
From Jun 202625 Jun 2026 to 20 Nov 2026 in total+6.6 %+4.6 % 195 schemes
From Mar 202627 Mar 2026 to 20 Nov 2026 in total+20.4 %+18.1 % 195 schemes
From Dec 202526 Dec 2025 to 20 Nov 2026 in total+13.6 %+6.9 % 188 schemes
From Sep 202526 Sep 2025 to 20 Nov 2026 a year, compounded+13.0 %+9.0 % 182 schemes
From Jun 202527 Jun 2025 to 20 Nov 2026 a year, compounded+11.0 %+6.1 % 173 schemes
From Mar 202528 Mar 2025 to 20 Nov 2026 a year, compounded+12.5 %+11.9 % 169 schemes
From Dec 202427 Dec 2024 to 20 Nov 2026 a year, compounded+5.8 %+5.9 % 159 schemes
From Sep 202427 Sep 2024 to 20 Nov 2026 a year, compounded+5.2 %+1.6 % 148 schemes
From Jun 202428 Jun 2024 to 20 Nov 2026 a year, compounded+13.0 %+5.5 % 139 schemes
From Mar 202428 Mar 2024 to 20 Nov 2026 a year, compounded+13.8 %+9.9 % 133 schemes
From Dec 202329 Dec 2023 to 20 Nov 2026 a year, compounded+16.7 %+11.6 % 127 schemes
From Sep 202329 Sep 2023 to 20 Nov 2026 a year, compounded+19.4 %+14.6 % 118 schemes
Spread of falling weeks, a year

Root mean square of the weekly falls × √52 (rising weeks count as zero).

9.2 %24 Nov 2023 to 20 Nov 2026
Up capture

Its average change in the 92 weeks the category average rose, as a share of the category's.

91.8 %92 rising weeks
Down capture

The same for the 64 weeks the category average fell.

78.2 %64 falling weeks

Past performance may not be sustained in future.

Source: AMFI NAV files.

Category average = the plain average for the other schemes in the same AMFI category with the same figure (direct growth plans, each week's last NAV). It is not an index, and the scheme's place among them is not shown. Peers are today's schemes in today's category, so a scheme that has closed is not in the average, and SEBI re-sorted the categories in 2018.

52-week high NAV

Highest and lowest of 248 daily NAVs, 20 Nov 2025 to 20 Nov 2026, Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option.

Source: AMFI

₹40.229620 Nov 2026
52-week low NAV₹32.80272 Apr 2026

Calendar-year returns, Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

NAV to NAV · Source: AMFI
YearReturnFromTo
2025−3.47 % 31 Dec 2024 · NAV ₹36.642431 Dec 2025 · NAV ₹35.3723
2024+42.48 % 29 Dec 2023 · NAV ₹25.717831 Dec 2024 · NAV ₹36.6424
2023+38.59 % 30 Dec 2022 · NAV ₹18.556329 Dec 2023 · NAV ₹25.7178
2022−6.64 % 31 Dec 2021 · NAV ₹19.877130 Dec 2022 · NAV ₹18.5563
2021+20.88 % 31 Dec 2020 · NAV ₹16.443731 Dec 2021 · NAV ₹19.8771
2020+66.92 % 31 Dec 2019 · NAV ₹9.851131 Dec 2020 · NAV ₹16.4437
2019+7.15 % 31 Dec 2018 · NAV ₹9.193531 Dec 2019 · NAV ₹9.8511
2018−0.81 % 29 Dec 2017 · NAV ₹9.268231 Dec 2018 · NAV ₹9.1935
2017+6.36 % 30 Dec 2016 · NAV ₹8.714229 Dec 2017 · NAV ₹9.2682
2016−13.16 % 29 Dec 2015 · NAV ₹10.035130 Dec 2016 · NAV ₹8.7142

Past performance may not be sustained in future.

Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read

Monthly SIP of ₹10,000, Tata India Pharma & Healthcare Fund - Direct Plan - Growth Option

XIRR · Source: AMFI
PeriodInstalmentsPaid inValueXIRR, a year
1 year 1 Dec 2025 to 2 Nov 202612 ₹1,20,000₹1,32,366 20 Nov 2026 · NAV ₹40.2296+20.84 %

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Portfolios most like this one, Oct 2026

same category, other fund houses
Most alike and most unique funds →

Overlap is the sum, over stocks both hold, of the smaller of the two weights. A measured likeness, not a suggestion to switch.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

Questions about Tata India Pharma & Healthcare Fund

from the figures on this page

What are the top holdings of Tata India Pharma & Healthcare Fund?

At Oct 2026 end, Tata India Pharma & Healthcare Fund held 40 stocks (99.7% of the fund in equity). Largest: Sun Pharmaceutical Industries 7.89%, Abbott India 5.66%, Divi's Laboratories 5.41%, Healthcare Global Enterprises 5.25%, Dr. Reddy's Laboratories 5.14%; the top 10 make up 50.1%. Funds holding Sun Pharmaceutical Industries · Funds holding Abbott India · Funds holding Divi's Laboratories

What portfolio changes did Tata India Pharma & Healthcare Fund make in Oct 2026?

Compared with Sep 2026, by share count: 1 new, 12 added, 7 trimmed, 3 exited. Largest by value: Nestle India (new), Torrent Pharmaceuticals (added), Max Healthcare Institute (added), Sai Life Sciences (added).

Who manages Tata India Pharma & Healthcare Fund?

AMFI's scheme summary document names Rajat Srivastava for Tata India Pharma & Healthcare Fund (Tata Mutual Fund). Rajat Srivastava, fund manager portfolio

All schemes of Tata Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.